Clinical Trial Update: Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome [NA]

View source ↗

Summary

Terminated clinical trial comparing T2762 and Optive for moderate to severe dry eye syndrome; the update does not report efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• Optive
• T2762

Snippet

Sponsor: Laboratoires Thea | Conditions: Dry Eye Syndrome | NA | Status: TERMINATED